CTRI/2021/06/033958尚未招募1 期
Proof of concept study to evaluate possibility of reversal in clinically diagnosed brain death subjects following road traffic accident having diffuse axonal injury by extending aggressive critical care for 15 days along with laser and electric stimulation
Himanshu Bansal Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Both male and female, Age between 18 to 65 years old.
- •Individuals declared Brain dead from a traumatic brain injury having
- •diffuse axonal injury on MRI
- •Not willing for organ donation
- •Written informed consent from the legally acceptable representative of the patient
排除标准
- •Metallic clips/ metal implants or intracranial implants in the brain.
研究者
相似试验
进行中（未招募）
1 期
Benralizumab in Severe AsthmaSevere Eosinophilic AsthmaMedDRA version: 21.1Level: LLTClassification code 10068462Term: Eosinophilic asthmaSystem Organ Class: 100000004855EUCTR2019-003763-22-GBTayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside18
进行中（未招募）
1 期
A Proof of Concept Study to Investigate the use of Simvastatin as a Putative Anti-inflammatory Agent in Asthma - Simvastatin in AsthmaAsthmaEUCTR2005-001466-14-GBniversity of Dundee20
进行中（未招募）
3 期
The effect of dupilumab on airway twitchiness in severe asthmaAdult patients with severe asthma with type 2 inflammationRespiratoryISRCTN70810039niversity of Dundee20
进行中（未招募）
不适用
Proof of concept study to investigate the impact of BAY 58-2667 given intravenously in patients with acute decompensated chronic congestive heart failureEUCTR2005-004473-14-DEBayer HealthCare AG60
已完成
2 期
A prospective *proof of concept study* to evaluate the potential efficacy of ustekinumab in patients with moderate to severe hidradenitis suppurativa (acne ectopica)acne ectopicaacne inversa10040798hidradenitis suppurativaNL-OMON37989niversitair Medisch Centrum Groningen20